1-3 of 3
Keiichiro Honma, MD
Close
Sort by
Journal Articles

Ocular Adnexal Marginal Zone B Cell Lymphoma Has Characteristic Deletion at Chromosome Band 6q23.3-24.1 Whose Target Is TNFAIP3 .

Keiichiro Honma, MD, Shinobu Tsuzuki, MD, PhD, Masao Nakagawa, MD, PhD, Sivasundaram Karnan, MS, Won-Seog Kim, MD, Yoon-Duk Kim, MD, Young-Hyeh Ko, MD, Masao Seto, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2643.
https://doi.org/10.1182/blood.V110.11.2643.2643
Published: 2007
Journal Articles

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Jun Takizawa, MD, PhD, Sadao Aoki, MD, PhD, Kazue Takai, MD, Tohri Kurasaki, MD, Keiichiro Honma, MD, Masutaka Higashimura, MD, Kouichi Nagai, MD, Akihito Momoi, MD, PhD, Koji Nikkuni, MD, PhD, Yoshufusa Aizawa, MD
Journal: Blood
Blood (2005) 106 (11): 4734.
https://doi.org/10.1182/blood.V106.11.4734.4734
Published: 2005
Journal Articles

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Nobuhiro Tsukada, MD, PhD, Tatsuo Furukawa, MD, PhD, Hiromi Ito, Noriko Izumi, MD, Akihito Momoi, MD, Kiyoshi Okazuka, MD, Keiichiro Honma, MD, Masayoshi Masuko, MD, PhD, Shigeo Hashimoto, MD, PhD, Sadao Aoki, MD, PhD, Yoshifusa Aizawa, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 5076.
https://doi.org/10.1182/blood.V104.11.5076.5076
Published: 2004